20 results
·
20ms
·
Sources: EU EUDAMED, US FDA
INTRABLOCK BIOBALL HIP SYSTEM (IBS)
FDA 510(k)
FDA Class 2
·Orthopedic
FOERSTER SPONGE FORCEPS
FDA UDI
SONTEC INSTRUMENTS, INC.·00192896093164·FOERSTER SPONGE FORCEPS STRAIGHT SERRATED TIP
KING SEPTEMS
FDA Adverse Event
Malfunction
·KING SEPTEMS·Product code LMA·November 1, 2012
SYNTHETIC EXAM GLOVE POWDER FREE COATED WITH ALLOGEL (GREEN/ BLUE / WHITE / MAGENTA / CLEAR - NON COLORED)
FDA 510(k)
FDA Class 1
·General Hospital
ORTHODONTIC FLOWABLE BRACKET ADHESIVE
FDA 510(k)
FDA Class 2
·Dental
UniTip High Resolution Catheter
FDA UDI
Unisensor AG·07640172973295·
UniTip High Resolution Catheter
FDA UDI
Unisensor AG·07640172970690·
UniTip High Resolution Catheter
FDA UDI
Unisensor AG·07640172970676·
UniTip High Resolution Catheter
FDA UDI
Unisensor AG·07640172970645·
UniTip High Resolution Catheter
FDA UDI
Unisensor AG·07640172970621·
UniTip High Resolution Catheter
FDA UDI
Unisensor AG·07640172970638·
UniTip High Resolution Catheter
FDA UDI
Unisensor AG·07640172970683·
UniTip High Resolution Catheter
FDA UDI
Unisensor AG·07640172970652·
UniTip High Resolution Catheter
FDA UDI
Unisensor AG·07640172970669·
SCRDRIVERSHAFT T25 F/URS
FDA Adverse Event
Malfunction
·SYNTHES GMBH·Product code HXX·May 22, 2013
PARADIGM REAL-TIME INSULIN INFUSION PUMP
FDA Adverse Event
Malfunction
·MEDTRONIC MINIMED·Product code OYC·September 26, 2014
36CM PERM CATH KIT X5
FDA Adverse Event
Malfunction
·COVIDIEN·Product code LFJ·June 10, 2011
KING LAD SILI CONE SINGLE USE, King Systems, 10 devices/case, ETO Sterile Size 4 / Adult Silicone King LAD¿ Patient Size: 50-70kg
FDA Enforcement
Class II
·Terminated·King Systems Corp.·November 28, 2012
Signa PET/MR (K163619, K142098) Product Usage: The SIGNA PET/MR system combines magnetic resonance diagnostic devices (MRDD) and Positron Emission Tomography (PET) scanners that provide registration and fusion of high resolution physiologic and anatomic information, acquired simultaneously and isocentrically. The combined system maintains independent functionality of the MR and PET devices, allowing for single modality MR and/or PET imaging. These systems are intended to be utilized by appropriately trained health care professionals to aid in the detection, localization, and diagnosis of diseases and disorders. The MR is intended to produce transverse, sagittal, coronal and oblique cross-sectional MR images, spectroscopic images and/or spectra, and displays the internal structure and/or function of the human body. Other physical parameters derived from the images and/or spectra may also be produced. Depending on the region of interest, approved contrast agents may be used, as described in their labeling. This system may also be used for imaging during interventional procedures when performed with MR compatible devices, such as MR safe biopsy needles. The PET images and measures the distribution of PET radiopharmaceuticals in humans to aid the physician in determining various metabolic (molecular) and physiologic functions within the human body for evaluation of diseases and disorders such as, but not limited to, cardiovascular disease, neurological disorders and cancer. The combined system utilizes the MR for radiationfree attenuation correction maps for PET studies. The system provides inherent anatomical reference for the fused PET and MR images due to precisely aligned MR and PET image coordinate systems.
FDA Enforcement
Class II
·Terminated·GE Medical Systems, LLC·August 23, 2017
Signa PET/MR (K163619, K142098) Product Usage: The SIGNA PET/MR system combines magnetic resonance diagnostic devices (MRDD) and Positron Emission Tomography (PET) scanners that provide registration and fusion of high resolution physiologic and anatomic information, acquired simultaneously and isocentrically. The combined system maintains independent functionality of the MR and PET devices, allowing for single modality MR and/or PET imaging. These systems are intended to be utilized by appropriately trained health care professionals to aid in the detection, localization, and diagnosis of diseases and disorders. The MR is intended to produce transverse, sagittal, coronal and oblique cross-sectional MR images, spectroscopic images and/or spectra, and displays the internal structure and/or function of the human body. Other physical parameters derived from the images and/or spectra may also be produced. Depending on the region of interest, approved contrast agents may be used, as described in their labeling. This system may also be used for imaging during interventional procedures when performed with MR compatible devices, such as MR safe biopsy needles. The PET images and measures the distribution of PET radiopharmaceuticals in humans to aid the physician in determining various metabolic (molecular) and physiologic functions within the human body for evaluation of diseases and disorders such as, but not limited to, cardiovascular disease, neurological disorders and cancer. The combined system utilizes the MR for radiationfree attenuation correction maps for PET studies. The system provides inherent anatomical reference for the fused PET and MR images due to precisely aligned MR and PET image coordinate systems.
FDA Recall
Terminated
·GE Medical Systems, LLC·Product code LNH·May 11, 2017